OB Complete Premier description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

OB Complete Premier

Vertical Pharmaceuticals Inc.

OB Complete™ Premier


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

PRESCRIBING INFORMATION

Supplement Facts
Serving Size: 1 Tablet
Servings Per Box: 30
For Pregnant and Lactating Women
Amount per Serving % Daily Value
Vitamin A (Beta Carotene) 2100 IU 26%
Vitamin C (Calcium Ascorbate) 120 mg 200%
Vitamin D3 (Cholecalciferol) 800 IU 200%
Vitamin E (d-Alpha Tocopheryl Succinate) 20 IU 67%
Vitamin B1 (Thiamine Mononitrate) 2 mg 118%
Vitamin B2 (Riboflavin) 3.4 mg 170%
Vitamin B3 (Niacinamide) 10 mg 50%
Vitamin B6 (Pyridoxine HCl) 10 mg 400%
Folate 1 mg 125%
Vitamin B12 (Cyanocobalamin) 15 mcg 188%
Minerals
Calcium (as DimaCal® Di-Calcium Malate)* 100 mg 8%
Ferronyl Carbonyl Iron (Elemental Iron) 30 mg 167%
Sumalate®† (Elemental Iron) 20 mg 111%
Magnesium (as Di-Magnesium Malate)* 15 mg 3%
Zinc (as TRAACS® Zinc Glycinate Chelate) 10 mg 67%
Copper 1 mg 50%

Other Ingredients: Microcrystalline Cellulose, Di Cal Phosphate, Croscarmellose Sodium, Hypromellose, Titanium Dioxide, Fumed Silica, Stearic Acid, Magnesium Stearate, Acacia, Polyethylene Glycol, Polyvinylpyrrolidone, Ethyl Cellulose, Talc, Polysorbate 80, Castor Oil, and FD&C Red #40 Lake.

OB COMPLETE PREMIER DESCRIPTION

OB Complete™ Premier is a pink tablet, imprinted "VPO43".

INDICATIONS

OB Complete™ Premier is a prescription multivitamin/ multimineral indicated for use in improving the nutritional status of women prior to conception, throughout pregnancy, and in the postnatal period for both lactating and non-lactating mothers.

OB COMPLETE PREMIER CONTRAINDICATIONS

This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

PRECAUTIONS

Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient. Folic acid in doses above 0.1 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations progress. Allergic sensitization has been reported following both oral and parenteral administration of folic acid.

WARNING
Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. KEEP THIS PRODUCT OUT OF REACH OF CHILDREN. In case of accidental overdose, call a doctor or poison control center immediately.

DRUG INTERACTIONS

OB Complete™ Premier tablets are not recommended for and should not be given to patients receiving levodopa because the action of levodopa is antagonized by pyridoxine.

OB COMPLETE PREMIER ADVERSE REACTIONS

Adverse reactions have been reported with specific vitamins and minerals but generally at levels substantially higher than those contained herein. However, allergic and idiosyncratic reactions are possible at lower levels. Iron, even at the usual recommended levels, has been associated with gastrointestinal intolerance in some patients.

OB COMPLETE PREMIER DOSAGE AND ADMINISTRATION

One tablet daily or as prescribed by a physician.

HOW SUPPLIED

OB Complete™ Premier is available in carton unit dose pack of 30 (3 child resistant blister cards of 10 tablets per card). 68025-043-30

STORAGE

Store at controlled room temperature 15°-30°C (59°-86°F) [See USP]. Protect from light, moisture and excessive heat.

KEEP THIS PRODUCT OUT OF REACH OF CHILDREN.

Rx Only.

Call your doctor about side effects. You may report side effects by calling 877-95-VERTI (877-958-3784).

Sumalate® (ferrous, asparto glycinate) is a registered trademark of Albion International, Inc., Clearfield, Utah

U.S. Pat. No. 6,716,814
U.S. Pat. No. 5,516,925
U.S. Pat. No. 8,007,846
And patents pending (including: U.S. Pat. No. 13/189,893 and U.S. Pat. Appl. No. 61/538,028)

*DimaCal and TRAACS are registered trademarks of Albion Laboratories, Inc.

Malates covered by U.S. Patent 6,706,904, Chelate covered U.S. Patent 7,838,042; and patents pending.

Manufactured for: Vertical Pharmaceuticals, Inc.
Sayreville, NJ 08872

PRINCIPAL DISPLAY PANEL - 3 Blister Pack Carton

Part of the
Complete
Family of Next
Generation
Prenatal
Nutrition.
For You and
Your Baby
Before, During,
and After
Pregnancy

NEW
OB
COMPLETE

Premier

One Tablet Daily

  • 1 mg Folate
  • 800 IU Vitamin D3
  • 100 mg Calcium
    (as DimaCal®
    di-calcium malate)*

68025-043-30
Rx Only

VERTICAL
PHARMACEUTICALS, INC.

OB Complete Premier

OB Complete Premier

.Beta.-Carotene, Calcium Ascorbate, Cholecalciferol, .Alpha.-Tocopherol Acetate, D-, Thiamine Mononitrate, Riboflavin, Niacinamide, Pyridoxine Hydrochloride, Folic Acid, Cyanocobalamin, Calcium Malate, Iron, Ferrous Asparto Glycinate, Magnesium Malate, Zinc Glycinate, and Copper TABLET, COATED

Product Information

Product Type Dietary supplement Item Code (Source) NDC:68025-043
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
.BETA.-CAROTENE .BETA.-CAROTENE 2100 [iU]
calcium ascorbate Ascorbic Acid 120 mg
CHOLECALCIFEROL CHOLECALCIFEROL 800 [iU]
.ALPHA.-TOCOPHEROL ACETATE, D- 20 [iU]
THIAMINE MONONITRATE THIAMINE ION 2 mg
RIBOFLAVIN RIBOFLAVIN 3.4 mg
NIACINAMIDE 10 mg
PYRIDOXINE HYDROCHLORIDE PYRIDOXINE 10 mg
FOLIC ACID FOLIC ACID 1 mg
Cyanocobalamin CYANOCOBALAMIN 15 ug
Calcium Malate Calcium Cation 100 mg
IRON PENTACARBONYL FERROUS CATION 30 mg
FERROUS ASPARTO GLYCINATE Ferrous Cation 20 mg
Magnesium Malate Magnesium Cation 15 mg
Zinc Glycinate Zinc Cation 10 mg
Cupric Glycinate Cupric Cation 1 mg

Inactive Ingredients

Ingredient Name Strength
cellulose, microcrystalline
CALCIUM PHOSPHATE
CROSCARMELLOSE SODIUM
HYPROMELLOSES
titanium dioxide
SILICON DIOXIDE
STEARIC ACID
MAGNESIUM STEARATE
ACACIA
POLYETHYLENE GLYCOLS
POVIDONES
ETHYLCELLULOSES
talc
polysorbate 80
castor oil
FD&C RED NO. 40
ALUMINUM OXIDE

Product Characteristics

Color Size Imprint Code Shape
PINK 20 mm VP043 OVAL

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 10 in 1 BLISTER PACK
2 NDC:68025-043-30 3 in 1 CARTON

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
2010-12-31


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.